Seven Eight Capital, LP Novavax Inc Transaction History

Seven Eight Capital, LP

  • $1.05 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$8.86 - $25.04 $50,546 - $142,853
-5,705 Reduced 22.22%
19,970 $205,000
Q3 2022

Nov 10, 2022
BUY
$18.2 - $76.12 $467,285 - $1.95 Million
25,675 New
25,675 $467,000
Q4 2020

Feb 09, 2021
SELL
$78.74 - $139.5 $184,251 - $326,430
-2,340 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$79.44 - $178.51 $185,889 - $417,713
2,340 New
2,340 $254,000

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email